Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease and the Risk of Nephrogenic Systemic Fibrosis: Radiology In Training

被引:10
作者
Alabousi, Mostafa [1 ]
Davenport, Matthew S. [2 ,3 ]
机构
[1] McMaster Univ, Dept Radiol, 1280 Main St W, Hamilton, ON L8S 4L8, Canada
[2] Michigan Med, Dept Radiol, Ann Arbor, MI USA
[3] Michigan Med, Dept Urol, Ann Arbor, MI USA
关键词
CONSENSUS STATEMENTS; AMERICAN-COLLEGE; LIVER-DISEASE; HEMODIALYSIS; SAFETY; AGENTS; EXPOSURE;
D O I
10.1148/radiol.2021210044
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
A 66-year-old male patient with end-stage chronic kidney disease undergoing maintenance dialysis and with a history of group I intravenous gadolinium-based contrast media (GBCM) administration presented with clinical and pathologic findings consistent with nephrogenic systemic fibrosis. A summary of the evidence and recommendations for use of intravenous GBCM in patients with kidney disease is presented. (C) RSNA, 2021
引用
收藏
页码:279 / 284
页数:6
相关论文
共 47 条
[1]   Nephrogenic Systemic Fibrosis and Gadolinium-Based Contrast Agents [J].
Abu-Alfa, Ali K. .
ADVANCES IN CHRONIC KIDNEY DISEASE, 2011, 18 (03) :188-198
[2]   Nephrogenic Systemic Fibrosis: Change in Incidence Following a Switch in Gadolinium Agents and Adoption of a Gadolinium Policy-Report from Two US Universities [J].
Altun, Ersan ;
Martin, Diego R. ;
Wertman, Rebecca ;
Lugo-Somolinos, Aida ;
Fuller, Edwin R., III ;
Semelka, Richard C. .
RADIOLOGY, 2009, 253 (03) :689-696
[3]  
American College of Radiology, 2020, MAN CONTR MED
[4]  
[Anonymous], ESUR guidelines on contrast agents
[5]  
[Anonymous], 2010, FDA DRUG SAF COMM NE
[6]   A Systematic Review of 639 Patients with Biopsy-confirmed Nephrogenic Systemic Fibrosis [J].
Attari, Hanieh ;
Cao, Yan ;
Elmholdt, Tina R. ;
Zhao, Yize ;
Prince, Martin R. .
RADIOLOGY, 2019, 292 (02) :376-386
[7]  
Bennett Charles L, 2012, Clin Kidney J, V5, P82
[8]   Quantification of gadolinium in fresh skin and serum samples from patients with nephrogenic systemic fibrosis [J].
Christensen, Kevin N. ;
Lee, Christine U. ;
Hanley, Matthew M. ;
Leung, Nelson ;
Moyer, Thomas P. ;
Pittelkow, Mark R. .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2011, 64 (01) :91-96
[9]   Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: Retrospective study of a renal replacement therapy cohort [J].
Collidge, Tara Anne ;
Thomson, Peter Campbell ;
Mark, Patrick Barry ;
Traynor, James Phillip ;
Jardine, Alan George ;
Morris, Scott Thomas William ;
Simpson, Keith ;
Roditi, Giles Hannibal .
RADIOLOGY, 2007, 245 (01) :168-175
[10]   Risk of Nephrogenic Systemic Fibrosis from Gadoxetic Acid in Patients with Severe Kidney Disease [J].
Davenport, Matthew S. ;
Shankar, Prasad R. .
RADIOLOGY, 2020, 297 (03) :563-564